Profile

Stephen B. Tatter, M.D., Ph.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

103 Ratings
19 Comments

Stephen B. Tatter, M.D., Ph.D.

Professor,


Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor

Contact Information

Department: 336-716-4081

Insurance Accepted »

Media Medical Expert »

Related Links

Education & Training

  • B.S., University of Michigan/Ann Arbor, 1982
  • M.D., Cornell University Medical College, 1990
  • Ph.D., Rockefeller University, 1990
  • Residency, Surgery, Massachusetts Gen Hosp, 1996
  • Fellowship, Harvard Medical School, 1997

NPI Number

  • 1831178151
Stephen B. Tatter, M.D., Ph.D.

Doctor Rating

4.7 out of 5

103 Ratings
19 Comments

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery
Comprehensive Cancer Center
Brain Tumor Center of Excellence

Research Interests

cancer/oncogenesis, cognition/learning, health services, research/outc, neurosciences/behavior, physical/muscular function

Contact Information

Academic: 336-716-4047 | Department: 336-716-4081

Media Medical Expert »

Related Links

Recent Publications

Mu F, Lucas JT Jr, Watts JM, Johnson AJ, Daniel Bourland J, Laxton AW, Chan MD, Tatter SB. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015;22(3):561-565.

Liu A, Kuhn EN, Lucas JT Jr, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536-542.

Lucas JT Jr, Huang AJ, Mott RT, Lesser GJ, Tatter SB, Chan MD. Anaplastic ganglioglioma: a report of three cases and review of the literature. J Neurooncol. 2015;123(1):171-177.

Lucas JT Jr, Colmer HG IV, White L, Fitzgerald N, Isom S, Bourland JD, Laxton AW, Tatter SB, Chan MD. Competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage after whole-brain radiation therapy failure: who actually dies of their brain metastases?. Int J Radiat Oncol Biol Phys. 2015;92(5):1008-1015.

Rodriguez A, Tatter SB. Neurosurgical management of brain metastases. Curr Probl Cancer. 2015;39(2):89-98.

Johnson AG, Ruiz J, Hughes R, Page BR, Isom S, Lucas JT, McTyre ER, Houseknecht KW, Ayala-Peacock DN, Bourland DJ, Hinson WH, Laxton AW, Tatter SB, Debinski W, Watabe K, Chan MD. Impact of systemic targeted agents on the clinical outcomes of patients with brain metastases. Oncotarget. 2015;6(22):18945-55.

Triffo WJ, Bourland JD, Couture DE, McMullen KP, Tatter SB, Morris PP. Definitive treatment of vein of Galen aneurysmal malformation with stereotactic radiosurgery. J Neurosurg. 2014;120(1):120-125.

Lester SC, Taksler GB, Kuremsky JG, Lucas JT Jr, Ayala-Peacock DN, Randolph DM II, Bourland JD, Laxton AW, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014;120(3):433-441.

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Bourland JD, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Weller M, Marshall K, Lovato JF, Bourland JD, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Chan MD. Single-institution retrospective series of gamma knife radiosurgery in the treatment of multiple sclerosis-related trigeminal neuralgia: factors that predict efficacy. Stereotact Funct Neurosurg. 2014;92(1):53-58.

Lucas JT Jr, Nida AM, Isom S, Marshall K, Bourland JD, Laxton AW, Tatter SB, Chan MD. Predictive nomogram for the durability of pain relief from gamma knife radiation surgery in the treatment of trigeminal neuralgia. Int J Radiat Oncol Biol Phys. 2014;89(1):120-126.

Paulsson AK, McMullen KP, Peiffer AM, Hinson WH, Kearns WT, Johnson AJ, Lesser GJ, Ellis TL, Tatter SB, Debinski W, Shaw EG, Chan MD. Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma. Am J Clin Oncol. 2014;37(2):177-181.

Strowd RE, Swett K, Harmon M, Carter AF, Pop-Vicas A, Chan M, Tatter SB, Ellis T [deceased], Blevins M, High K, Lesser GJ. Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol. 2014;16(12):1639-1644.

Zheng ZL, Morykwas M, Campbell D, McGee M, Hollingsworth C, Adams F, Mays J, Tatter S, Argenta L. Mechanical tissue resuscitation at the site of traumatic brain injuries reduces the volume of injury and hemorrhage in a swine model. Neurosurgery. 2014;75(2):152-162.

Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014;16(9):1283-1288.

Neal MT, Chan MD, Lucas JT Jr, Loganathan A, Dillingham C, Pan E, Stewart JH IV, Bourland JD, Shaw EG, Tatter SB, Ellis TL. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg. 2014;82(6):1250-1255.

Witcher M, Moran R, Tatter SB, Laxton AW. Neuronal oscillations in Parkinson's disease. Front Biosci (Landmark Ed). 2014;19():1291-1299.

Paulsson AK, Holmes JA, Peiffer AM, Miller LD, Liu W, Xu J, Hinson WH, Lesser GJ, Laxton AW, Tatter SB, Debinski W, Chan MD. Comparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastoma. J Neurooncol. 2014;119(2):429-435.

Huang AJ, Huang KE, Page BR, Ayala-Peacock DN, Lucas JT Jr, Lesser GJ, Laxton AW, Tatter SB, Chan MD. Risk factors for leptomeningeal carcinomatosis in patients with brain metastases who have previously undergone stereotactic radiosurgery. J Neurooncol. 2014;120(1):163-169.

Kuhn EN, Taksler GB, Dayton O, Loganathan A, Bourland D, Tatter SB, Laxton AW, Chan MD. Is there a tumor volume threshold for postradiosurgical symptoms? A single-institution analysis. Neurosurgery. 2014;75(5):536-545.

Page BR, Huang AJ, Huang KE, Laxton AW, Tatter SB, Chan MD. Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S245.

Randolph DM, Peiffer AM, Paulsson AK, Hinson W, Laxton AW, Tatter SB, Debinski W, Chan MD. Does delay of start of radiation affect clinical outcomes of glioblastoma [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S295.

Holmes JA, Paulsson A, Peiffer AM, Miller LD, Xu J, Hinson WH, Lesser GJ, Tatter SB, Debinski W, Chan MD. Genomic predictors of infield and marginal failure for glioblastoma treated with concurrent radiation therapy and temozolomide: a step towards personalized radiation fields? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S291-S292.

Lucas JT, Ayala-Peacock DN, Piazza M, Kuremsky JG, Page BR, Randolph D, Fitzgerald N, Holmes JA, Soike M, Tatter SB, Chan MD. A propensity score adjusted analysis of patients receiving up-front SRS versus WBRT: does the use of upfront WBRT really affect neurologic death? [abstract]. Int J Radiat Oncol Biol Phys. 2014;90(Suppl 1):S315-S316.

Debinski W, Rodriguez A, Gibo D, Tatter SB, Mott R, Lively M, Miller L, Seals DF. Functional presence of M2 macrophage markers in GBM tumor cells [abstract]. Neuro Oncol. 2014;16(Suppl 3):.

Liu Y, Konrad PE, Neimat JS, Tatter SB, Yu H, Datteri RD, Landman BA, Noble JH, Pallavaram S, Dawant BM, D'Haese PF. Multisurgeon, multisite validation of a trajectory planning algorithm for deep brain stimulation procedures. IEEE Trans Biomed Eng. 2014;61(9):2479-2487.

Mohammadi AM, Hawasli AH, Rodriguez A, Schroeder JL, Laxton AW, Elson P, Tatter SB, Barnett GH, Leuthardt EC. The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study. Cancer Med. 2014;3(4):971-979.

Strowd R, Russell G, Harmon M, Carter A, Chan M, Tatter S, Laxton A, High K, Lesser G. A pilot study of high-dose influenza vaccine immunogenicity in patients with primary central nervous system malignancy [abstract]. Neuro Oncol. 2014;16(Suppl 5):v207.

Brocker DT, Swan BD, Turner DA, Gross RE, Tatter SB, Koop MM, Bronte-Stewart H, Grill WM. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol. 2013;239():60-67.

Peiffer AM, Leyrer CM, Greene-Schloesser DM, Shing E, Kearns WT, Hinson WH, Tatter SB, Ip EH, Rapp SR, Robbins ME [deceased], Shaw EG, Chan MD. Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013;80(8):747-753.

Powers AK, Neal MT, Argenta LC, Wilson JA, DeFranzo AJ, Tatter SB. Vacuum-assisted closure for complex cranial wounds involving the loss of dura mater. J Neurosurg. 2013;118(2):302-308.

Chan MD, Shaw EG, Tatter SB. Radiosurgical management of trigeminal neuralgia. Neurosurg Clin N Am. 2013;24(4):613-621.

Kuhn E, Taksler GB, Dayton O, Loganathan A, Bourland J, Ellis TL [deceased], Laxton AW, Shaw EG, Chan MD, Tatter SB. Adverse toxicity after stereotactic radiosurgery for treatment of meningiomas [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S259.

Kuremsky JG, Lester SC, Lucas JT, Randolph DM, Tatter SB, Chan MD. Clinical and economic outcomes of patients with brain metastases based on whether metastases are symptomatic or not: an argument for routine brain screening [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S178-S179.

Lucas JT, Colmer HG, White GL, Isom SP, Ellis TL [deceased], Urbanic JJ, Tatter SB, Chan MD. A competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage following whole brain radiation therapy failure (WBRT): who actually dies of their brain metastases? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S52.

Randolph D, Peiffer AM, Klepin H, Ayala-Peacock DN, Lester SC, Laxton AW, Tatter SB, Shaw EG, Chan MD. Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S609.

Kuhn EN, Taksler GB, Dayton O, Loganathan AG, Vern-Gross TZ, Bourland JD, Laxton AW, Chan MD, Tatter SB. Patterns of recurrence after stereotactic radiosurgery for treatment of meningiomas. Neurosurg Focus. 2013;35(6):E14.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL [deceased], McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013;73(4):641-647.

Mohammadi A, Hawasli A, Rodriguez A, Schroeder J, Laxton A, Elson P, Tatter S, Barnett G, Leuthardt E. Laser Interstitial Thermal Therapy (LITT) as a treatment modality for difficult-to-access high grade gliomas: a multi-center study [abstract]. Neuro Oncol. 2013;15(Suppl 3):221.

Bergene J, Walker J, Tatter S, Sarwal A. Cerebral vasospasm post craniopharyngioma surgery with diabetes insipidus: challenges of management [abstract]. Crit Care Med. 2013;41(12 Suppl 1):A330.

Monjazeb AM, Ayala D, Jensen C, Case LD, Bourland JD, Ellis TL, McMullen KP, Chan MD, Tatter SB, Lesser GJ, Shaw EG. A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2012;82(2):743-748.

Ruiz J, Case D, Enevold G, Rosdhal R, Tatter SB, Ellis TL, McQuellon RP, McMullen KP, Stieber VW, Shaw EG, Lesser GJ. A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas. J Neurooncol. 2012;106(3):611-617.

Geer CP, Simonds J, Anvery A, Chen MY, Burdette JH, Zapadka ME, Ellis TL, Tatter SB, Lesser GJ, Chan MD, McMullen KP, Johnson AJ. Does MR perfusion imaging impact management decisions for patients with brain tumors? A prospective study. AJNR Am J Neuroradiol. 2012;33(3):556-562.

Marshall K, Chan MD, McCoy TP, Aubuchon AC, Bourland JD, McMullen KP, deGuzman AF, Munley MT, Shaw EG, Tatter SB, Ellis TL. Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife radiosurgery. Neurosurgery. 2012;70(3):566-573.

Argenta LC, Zheng Z, Bryant A, Tatter SB, Morykwas MJ. A new method for modulating traumatic brain injury with mechanical tissue resuscitation. Neurosurgery. 2012;70(5):1281-1295.

Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e53-e59.

Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, Urbanic JJ, McMullen KP, Shaw EG, Tatter SB, Ellis TL. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg. 2012;116(5):978-983.

Renfrow JJ, DeTroye A, Chan M, Tatter S, Ellis T, McMullen K, Johnson A, Mott R, Lesser GJ. Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report. J Neurooncol. 2012;107(3):659-663.

Attia A, Chan MD, Mott RT, Russell GB, Seif D, Bourland JD, Deguzman AF, Ellis TL, McMullen KP, Munley MT, Tatter SB, Shaw EG. Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery. J Neurooncol. 2012;108(1):179-185.

Attia A, Tatter SB, Weller M, Marshall K, Lovato JF, Bourland JD, Ellis TL [deceased], McMullen KP, Shaw EG, Chan MD. CT-only planning for Gamma Knife radiosurgery in the treatment of trigeminal neuralgia: methodology and outcomes from a single institution. J Med Imaging Radiat Oncol. 2012;56(4):490-494.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurosurgery

Clinical Interests

Parkinson's Disease, Neurosurgery, Brain Tumors, Pituitary Tumors, Gamma Knife, Tremor
Stephen B. Tatter, M.D., Ph.D.

Stephen B. Tatter, M.D., Ph.D.

Professor, Neurosurgery
Comprehensive Cancer Center
Brain Tumor Center of Excellence

Doctor Rating

4.7 out of 5

Stephen B. Tatter, M.D., Ph.D.103 Ratings
19 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.6
Wait time at clinic
4.1



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

7/29/2015

Good.

7/6/2015

I had an outstanding experience with Dr. Stephen Tatter. He explained my situation very well and in a way that I could easily understand my situation. He also reiterated all of my options and explained why the option chosen was the best for me.

6/16/2015

This was my first visit with Dr. Tatter. He and all of his staff made me feel welcome, valued, heard, and understood.

6/12/2015

I am cancer free so to me *Dr. Tatter is the best.

6/8/2015

Confident, professional, and put us at ease.

5/19/2015

Dr Tatter and his staff are truly exceptional

5/15/2015

Dr Tatter and PA Lowder both are encouraging and forthcoming about my condition. They are quick to respond to My Wake Health questions. I am very confident that I am in good hands.

5/8/2015

*Dr. Tatter is one of the finest doctors I have every had.

4/15/2015

all very good

3/9/2015

Both dr. & PA provided excellent service, answering ALL questions completely.

2/20/2015

Dr. Stephen Tatter and P.A. Rich Lowder exhibit the qualities all physicians should have: Compassionate, personable,extremely knowledgeable yet able to converse at patient level, providers of hope. I am extremely grateful to have them as my partners in health. While I am fortunate that my prognosis and status are so positive, I feel certain that they provide hope and demonstrate compassion for those patients who truly have difficult options. Thanks, Dr. Tatter and Rich!

2/18/2015

Very good.

2/10/2015

Doctor Tatter is the best!!!!!

1/13/2015

Dr. Tatter took his time time explaining the GK procedure and addressed mine and my husband questions and concerns. I felt I was primary focus the whole time I was in the room.

1/1/2015

good

12/18/2014

Overall it was a great experience, the doctor took the time to talk and explain my condition, listened to my concerns and answered any questions I had about my condition. He even took the time to draw diagrams for explanation. I feel very confident and assured I am getting the best possible care!

10/29/2014

*Dr. Tatter and PA *Lowder are outstanding representatives of the Baptist Hospital and *Bowman Gray.

10/27/2014

*Dr. Tatter is great. #5. No meds.

10/8/2014

The best in the world! Love *Dr. Tatter & *Dr. Lauder and their staff. Awesome! Loving, kind, caring people.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.